In discriminating DLB from AD clinically, dopamine transporter (DAT) imaging [17] and [123I] MIBG [18] are useful because they detect early disturbances of the nigrostriatal pathway or peripheral sympathetic nervous system in patients with DLB. This evidence concerns the gene SLC6A3 and Lewy body dementia.